BVF Partners L P/il, 10% Owner at FIVE PRIME THERAPEUTICS, INC. (FPRX), bought 29,314 shares at $3.90 ($114K) on 2019-10-29, disclosed to the SEC on 2019-10-31.
Open-market purchase of $114k FPRX by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.90 | 240 | $935 | 0.8% |
| 2 | $3.90 | 1,027 | $4K | 3.5% |
| 3 | $3.90 | 1,133 | $4K | 3.9% |
| 4 | $3.89 | 1,456 | $6K | 5.0% |
| 5 | $3.89 | 8,236 | $32K | 28.2% |
| 6 | $3.89 | 10,389 |
| $40K |
| 35.5% |
| 7 | $3.85 | 504 | $2K | 1.7% |
| 8 | $3.85 | 2,913 | $11K | 9.9% |
| 9 | $3.85 | 3,416 | $13K | 11.6% |
| Total | $3.88 avg | 29,314 | $114K | 100% |
| Filing → |
| KYMR | BUY | 2022-05-31 | $8.3M | — | Filing → |
| IDYA | SELL | 2021-02-04 | $835K | — | Filing → |
| XOMA | BUY | 2020-03-27 | $284K | — | Filing → |